Across TCGA pan-cancer cohorts, RNA5SP284 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNA5SP284’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RNA5SP284 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP284 is over-expressed in tumor, although a few such as BRCA and STAD show the opposite, repressed pattern.

BLCA, HNSC, and LUSC are the cancer types where RNA5SP284 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP284 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	IV	+1.533	.007	8	view →
HNSC	All	All	+0.209	.013	6	view →
LUSC	All	All	+0.226	.016	2	view →
BRCA	All	III,IV	−0.194	.008	2	view →
STAD	Male	IV	−1.315	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RNA5SP284 RNA expression & survival · all RNA5SP284 data types